Skip to main content
. 2023 May 26;11(6):1409. doi: 10.3390/microorganisms11061409

Table 3.

Summary of time-kill and checkerboard assessments of different combinations in different bacteria (n = 8).

Combination [(FOS) + (MEM)] mg/L 6-h Effect 24-h Effect 24-h log10 Killing ∆ 24 h Checkerboard
Fosfomycin + Meropenem Isolate Ab 3
0.25 FOS + 0.02 MEM (32, 2) Synergy None >+2 Growth
0.25 FOS + 0.12 MEM (32, 8) Bactericidal Bactericidal >−5 Synergy
0.5 FOS + 0.01 MEM (64, 0.5) None Bactericidal >−5 Growth
0.5 FOS + 0.25 MEM (64, 16) Bactericidal Bactericidal −6 Partial synergy
Fosfomycin + Amikacin Isolate Ab 1
0.5 FOS + 0.004 AK (64, 8) None Synergy −2 Growth
Fosfomycin + Tigecycline Isolate Ab 4
0.5 FOS + 0.02 TGC (64, 0.06) None Bactericidal −3 Partial synergy

Abbreviation: FOS = fosfomycin, MEM = meropenem, TGC = tigecycline, AK = amikacin, Ab = A. baumannii, Bactericidal effect = ≥3 log10 reduction in CFU/mL after 24 h compared with the starting inoculum (0 h). Synergy = ≥2 log10 reduction in CFU/mL after 24 h compared with in the antibiotic alone. Difference () in bacterial concentration in log10 CFU/mL at 24 h compared with the starting inoculum. Bactericidal effect (≥3 log10 reduction in CFU/mL after 24 h) and synergy (≥2 log10 reduction in CFU/mL at 24 h with the combination as compared with the most active single drug). Checkerboard FICI values of x ≤ 0.5 (synergism) and 0.5 < x < 1 (partial synergy).